These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11203037)

  • 21. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
    Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME
    Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olanzapine vs. haloperidol in the treatment of elderly chronic schizophrenia patients.
    Barak Y; Shamir E; Zemishlani H; Mirecki I; Toren P; Weizman R
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1199-202. PubMed ID: 12452546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.
    Tohen M; Goldberg JF; Gonzalez-Pinto Arrillaga AM; Azorin JM; Vieta E; Hardy-Bayle MC; Lawson WB; Emsley RA; Zhang F; Baker RW; Risser RC; Namjoshi MA; Evans AR; Breier A
    Arch Gen Psychiatry; 2003 Dec; 60(12):1218-26. PubMed ID: 14662554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex differences in clinical response to olanzapine compared with haloperidol.
    Goldstein JM; Cohen LS; Horton NJ; Lee H; Andersen S; Tohen M; Crawford A; Tollefson G
    Psychiatry Res; 2002 May; 110(1):27-37. PubMed ID: 12007591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.
    Kinon BJ; Basson BR; Gilmore JA; Tollefson GD
    J Clin Psychiatry; 2001 Feb; 62(2):92-100. PubMed ID: 11247108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sildenafil use in patients with olanzapine-induced erectile dysfunction.
    Atmaca M; Kuloglu M; Tezcan E
    Int J Impot Res; 2002 Dec; 14(6):547-9. PubMed ID: 12494295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.
    David SR; Taylor CC; Kinon BJ; Breier A
    Clin Ther; 2000 Sep; 22(9):1085-96. PubMed ID: 11048906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: results of the Japan multicenter, double-blind olanzapine trial.
    Ishigooka J; Inada T; Miura S
    Psychiatry Clin Neurosci; 2001 Aug; 55(4):403-14. PubMed ID: 11442893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olanzapine for primary negative symptoms.
    Licht RW
    Am J Psychiatry; 1998 Aug; 155(8):1133-4. PubMed ID: 9699711
    [No Abstract]   [Full Text] [Related]  

  • 30. Olanzapine and haloperidol: potential for neutropenia?
    Abdullah N; Voronovitch L; Taylor S; Lippmann S
    Psychosomatics; 2003; 44(1):83-4. PubMed ID: 12515844
    [No Abstract]   [Full Text] [Related]  

  • 31. Olanzapine versus haloperidol treatment in first-episode psychosis.
    Sanger TM; Lieberman JA; Tohen M; Grundy S; Beasley C; Tollefson GD
    Am J Psychiatry; 1999 Jan; 156(1):79-87. PubMed ID: 9892301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients.
    Esel E; Basturk M; Saffet Gonul A; Kula M; Tayfun Turan M; Yabanoglu I; Sofuoglu S
    Psychoneuroendocrinology; 2001 Aug; 26(6):641-7. PubMed ID: 11403983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olanzapine and tardive dyskinesia.
    Woods SW
    Br J Psychiatry; 1999 Oct; 175():391-2. PubMed ID: 10789313
    [No Abstract]   [Full Text] [Related]  

  • 35. Repeated episodes of hypothermia in a subject treated with haloperidol, levomepromazine, olanzapine, and thioridazine.
    Hägg S; Mjörndal T; Lindqvist L
    J Clin Psychopharmacol; 2001 Feb; 21(1):113-5. PubMed ID: 11199936
    [No Abstract]   [Full Text] [Related]  

  • 36. [Life threatening neuroleptic malignant syndrome due to olanzapine].
    Kopf A; Köster J; Schulz A; Krömker H; Becker T
    Psychiatr Prax; 2003 Jul; 30(5):279-82. PubMed ID: 12872187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine.
    Carlson CD; Cavazzoni PA; Berg PH; Wei H; Beasley CM; Kane JM
    J Clin Psychiatry; 2003 Aug; 64(8):898-906. PubMed ID: 12927004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between negative symptoms of schizophrenia and extrapyramidal side effects with haloperidol and olanzapine.
    Allan ER; Sison CE; Alpert M; Connolly B; Crichton J
    Psychopharmacol Bull; 1998; 34(1):71-4. PubMed ID: 9564201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comment: risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine.
    Lu ML; Shen WW
    Ann Pharmacother; 2002; 36(7-8):1292; author reply 1292-3. PubMed ID: 12086567
    [No Abstract]   [Full Text] [Related]  

  • 40. Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial.
    Beasley CM; Tollefson G; Tran P; Satterlee W; Sanger T; Hamilton S
    Neuropsychopharmacology; 1996 Feb; 14(2):111-23. PubMed ID: 8822534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.